Literature DB >> 23204897

Genetic variations of α-cardiac actin and cardiac muscle LIM protein in hypertrophic cardiomyopathy in South India.

Advithi Rangaraju1, Deepa Selvi Rani, Ml Satyanarayana, Narasimhan Calambur, Nalla Swapna, Pratibha Nallari.   

Abstract

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a disease of the heart muscle, with an autosomal dominant mode of inheritance. It is also known as the 'disease of the sarcomere', and is a major cause of morbidity and mortality worldwide. Mutations in the sarcomeric genes have been largely implicated in the manifestation of HCM. Modifier genes and environmental factors, along with causative mutation, add to the cumulative effect of the disease.
METHODS: In the present study, the role of the cardiac actin gene and the cardiac muscle LIM protein as contributors to HCM - through genetic variation - has been elucidated by screening the entire coding region in 100 control and 100 HCM subjects through polymerase chain reaction-based single-strand conformation polymorphism analysis and direct sequencing.
RESULTS: The authors could not find any novel or reported exonic variations in any of the genes in the studied population; however, intronic variations were revealed in the cardiac actin gene through direct sequencing. A case of compound heterozygosity was observed in a patient with a variation in intron 1, along with a novel heterozygous mutation in exon 7 (S215L) of α-tropomyosin.
CONCLUSIONS: The particular genes are highly conserved, and account for only 1.5% of HCM cases. They do not seem to play a major role in the genesis of HCM in the present population, thus confirming earlier reports of conserved sequences and ethnicity.

Entities:  

Keywords:  Alpha-tropomyosin; Cardiac actin; Cardiac muscle LIM protein; Hypertrophic cardiomyopathy

Year:  2012        PMID: 23204897      PMCID: PMC3383364     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  21 in total

1.  Cardiac and skeletal actin gene mutations are not a common cause of dilated cardiomyopathy.

Authors:  B M Mayosi; S Khogali; B Zhang; H Watkins
Journal:  J Med Genet       Date:  1999-10       Impact factor: 6.318

Review 2.  Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death.

Authors:  William J McKenna; Elijah R Behr
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

3.  Clinical and genetic characteristics of alpha cardiac actin gene mutations in hypertrophic cardiomyopathy.

Authors:  J Mogensen; A Perrot; P S Andersen; O Havndrup; I C Klausen; M Christiansen; P Bross; H Egeblad; H Bundgaard; K J Osterziel; G Haltern; H Lapp; P Reinecke; N Gregersen; A D Børglum
Journal:  J Med Genet       Date:  2004-01       Impact factor: 6.318

4.  A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies.

Authors:  D K Lahiri; J I Nurnberger
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

5.  Actin mutations in hypertrophic and dilated cardiomyopathy cause inefficient protein folding and perturbed filament formation.

Authors:  Søren Vang; Thomas J Corydon; Anders D Børglum; Melissa D Scott; Judith Frydman; Jens Mogensen; Niels Gregersen; Peter Bross
Journal:  FEBS J       Date:  2005-04       Impact factor: 5.542

6.  Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; W C Roberts
Journal:  Circulation       Date:  1979-04       Impact factor: 29.690

7.  Mutational analysis of the cardiac actin gene in familial and sporadic dilated cardiomyopathy.

Authors:  E Takai; H Akita; N Shiga; K Kanazawa; S Yamada; M Terashima; Y Matsuda; C Iwai; K Kawai; Y Yokota; M Yokoyama
Journal:  Am J Med Genet       Date:  1999-10-08

8.  Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin.

Authors:  J Martijn Bos; Rainer N Poley; Melissa Ny; David J Tester; Xiaolei Xu; Matteo Vatta; Jeffrey A Towbin; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Journal:  Mol Genet Metab       Date:  2005-12-13       Impact factor: 4.797

9.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

Authors:  B J Maron; J M Gardin; J M Flack; S S Gidding; T T Kurosaki; D E Bild
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

10.  No variants in the cardiac actin gene in Finnish patients with dilated or hypertrophic cardiomyopathy.

Authors:  Satu Kärkkäinen; Keijo Peuhkurinen; Pertti Jääskeläinen; Raija Miettinen; Päivi Kärkkäinen; Johanna Kuusisto; Markku Laakso
Journal:  Am Heart J       Date:  2002-06       Impact factor: 4.749

View more
  3 in total

Review 1.  Recent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian Descendants.

Authors:  Jessica Kraker; Shiv Kumar Viswanathan; Ralph Knöll; Sakthivel Sadayappan
Journal:  Front Physiol       Date:  2016-10-28       Impact factor: 4.566

2.  Novel Mutations in β-MYH7 Gene in Indian Patients With Dilated Cardiomyopathy.

Authors:  Deepa Selvi Rani; Archana Vijaya Kumar; Pratibha Nallari; Katakam Sampathkumar; Perundurai S Dhandapany; Calambur Narasimhan; Andiappan Rathinavel; Kumarasamy Thangaraj
Journal:  CJC Open       Date:  2021-08-08

3.  A novel arginine to tryptophan (R144W) mutation in troponin T (cTnT) gene in an indian multigenerational family with dilated cardiomyopathy (FDCM).

Authors:  Deepa Selvi Rani; Perundurai S Dhandapany; Pratibha Nallari; Calambur Narasimhan; Kumarasamy Thangaraj
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.